# Optimized Posterior Left Atrial Wall Ablation Strategy for PeAF

> **NCT06633523** · NA · NOT_YET_RECRUITING · sponsor: **Shanghai Chest Hospital** · enrollment: 384 (estimated)

## Conditions studied

- Persistent Atrial Fibrillation

## Interventions

- **PROCEDURE:** PVI + Posterior Wall Isolation (PWI) + Electrogram Ablation (EGM)
- **PROCEDURE:** PVI + Posterior Wall Isolation (PWI)
- **PROCEDURE:** Pulmonary Vein Isolation (PVI) alone

## Key facts

- **NCT ID:** NCT06633523
- **Lead sponsor:** Shanghai Chest Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-01
- **Primary completion:** 2025-09-01
- **Final completion:** 2026-01-01
- **Target enrollment:** 384 (ESTIMATED)
- **Last updated:** 2024-10-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06633523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06633523, "Optimized Posterior Left Atrial Wall Ablation Strategy for PeAF". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06633523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*